IN-STENT CORONARY ARTERY RESTENOSIS

This adverse event was reported 193 times

These drugs are most commonly taken by patients reporting IN-STENT CORONARY ARTERY RESTENOSIS:

# Drug Count
0 ASPIRIN 110
1 ASPIRIN 325 MG 110
2 ASPIRIN 81 MG 110
3 CLOPIDOGREL 94
4 PRASUGREL HYDROCHLORIDE 50
5 CLOPIDOGREL BISULFATE 29
6 ATORVASTATIN CALCIUM 28
7 METOPROLOL TARTRATE 22
8 SIMVASTATIN 21
9 METOPROLOL 17
See all common drugs associated with IN-STENT CORONARY ARTERY RESTENOSIS

IN-STENT CORONARY ARTERY RESTENOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FLAVOXATE HYDROCHLORIDE 1 0.0099
1 PRASUGREL HYDROCHLORIDE 50 0.0049
2 MIGLITOL 3 0.0031
3 CARTEOLOL HYDROCHLORIDE 1 0.0030
4 HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE 1 0.0023
5 ESTRADIOL CYPIONATE 1 0.0017
6 VARDENAFIL 1 0.0017
7 PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE 1 0.0015
8 SALSALATE 1 0.0011
9 POTASSIUM ACETATE 1 0.0007
See all drugs enriched for association with IN-STENT CORONARY ARTERY RESTENOSIS